Lehr Donald P.

Avg. Two Year Performance

10% Avg. Purchase Return
5% Compound
(1%) Avg. Sale Return
(1%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return37%19%9%90%10%
Purchase Success Rate2 of 21 of 21 of 21 of 21 of 2
Average Sale Return(27%)(13%)(28%)(14%)(1%)
Sale Success Rate3 of 113 of 113 of 113 of 110 of 11

Precigen, Inc.

Drugs » Biotechnology

Chief Legal Officer:

Holdings: 538.13K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--